iframe {
border: 1px solid #e4e5e6;
float:none !important

CEO Mark Capone talks about why patients and physicians choose Myriad when decisions matter most. “We recognize that patients are going to use the information we provide and it will transform their lives in incredible ways. Therefore, it is our responsibility to make sure that that information is correct.”

Myriad Genetics at J.P. Morgan Healthcare Conference

Paul J. Diaz, president and chief executive officer, Bryan Riggsbee, chief financial officer, and Dale Muzzey, chief scientific officer, presented at the 41st annual J.P. Morgan (JPM) Healthcare Conference.